Ageing is not a passive, uniform process of cellular wear but a tightly regulated sequence of molecular events governed by intricate networks of RNA-binding proteins, secreted factors, and intercellular signaling cascades. Among the most versatile — and perhaps underappreciated — participants in this process are platelets: anucleate cytoplasmic fragments originating from megakaryocytes that have long been regarded primarily as sentinels of hemostasis. Accumulating evidence, however, suggests that platelets are far more than clotting machinery; they carry a rich repertoire of messenger RNAs and regulatory proteins capable of communicating with distant tissues and shaping the systemic ageing milieu.
A study published in Nature Communications on 7 May 2026 by Liu, Wang, Wang and colleagues now sheds new light on the molecular underpinnings of this phenomenon. The investigators focused on HuR (Human antigen R, also known as ELAVL1), a ubiquitously expressed RNA-binding protein that stabilizes AU-rich element–containing messenger RNAs by binding their 3′-untranslated regions and thereby preventing their premature degradation. HuR is a well-established regulator of inflammation, stress response, and cell cycle progression, and prior work had hinted at its involvement in replicative senescence. The current study, however, provides the first direct evidence that HuR activity specifically within platelets governs a downstream secreted factor designated PSPF, and that the ensuing HuR-PSPF regulatory axis drives platelet infiltration into peripheral tissues — a process the authors demonstrate to be a principal coordinator of systemic ageing.
The mechanistic model proposed is compelling in its molecular precision. In aged organisms, dysregulation of platelet HuR alters the post-transcriptional fate of PSPF messenger RNA, modifying its stability and translational output in a manner that promotes platelet extravasation and tissue infiltration. Once deposited within organs, these HuR-conditioned platelets propagate pro-ageing signals through their secreted contents, accelerating the deterioration of tissue homeostasis. The investigators substantiate this chain of causation through a combination of genetic models, transcriptomic analyses, and functional assays, offering a degree of mechanistic resolution that distinguishes this work from more correlative studies in the field.
These findings are not without limitations. The study employs predominantly murine experimental systems, and the extent to which the HuR-PSPF axis operates analogously in human physiology remains to be established. The identity and precise mechanisms of action of PSPF itself also warrant further characterization, as does the question of whether platelet infiltration is a cause or, in part, also a consequence of the broader ageing program. Nevertheless, the therapeutic implications are considerable: HuR is a druggable target, and pharmacological modulation of its activity within platelets may represent a tractable strategy for attenuating age-related tissue deterioration. The convergence of RNA biology, platelet physiology, and geroscience opens a genuinely novel avenue for the development of molecular anti-ageing interventions.
Reference: Liu C, Wang Y, Wang W et al. Platelet HuR-PSPF regulatory axis coordinates systemic aging. Nature Communications. 2026 May 7. DOI: 10.1038/s41467-026 [Open Access]
Leave a Reply